Evolution of views on ANCA-associated glomerulonephritis


Cite item

Full Text

References

  1. Семенкова Е. Н. Поражение почек при гранулематозе Вегенера и микроскопическом полиартериите. В кн.: Тареева И. Е. (ред.). Нефрология. М.: Медицина; 2000. 291- 296.
  2. Booth A., Pusey С., Jayne D. Renal vasculitis- an update in 2004. Nephrol. Dial. Transplant. 2004; 19: 1964-1968.
  3. Couser W. Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy. Am. J. Kidney Dis. 1988; 11 (6): 449-464.
  4. Мухин Н. А., Козловская Л. В., Насонов Е. Л. и др. Клинические и патогенетические аспекты поражения почек, связанного с антителами к цитоплазме нейтрофилов. Вестн. РАМН 1995; 5: 34-39.
  5. Davies D. J., Moran J. E., Niall J. F. et al. Segmental necrotizing glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Br. Med. J. 1982; 285: 606.
  6. Van Der Woude F., Rasmussen N., Lobatto S. et al. Autoantibodies against neutrophil and monocytes: tool for diagnosis and marcer of disease activity in Wegener's granulomatosis. Lancet 1985; 4: 425-429.
  7. Jennette J. C., Wilkman A. S., Falk R. J. Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am. J. Pathol. 1989; 135: 921-930.
  8. Falk R., Jennette J. Thought about the classification of small vessel vasculitis. J. Nephrol. 2004; 17: 3-9.
  9. Falk R. J., Jennette J. C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N. Engl. J. Med. 1988; 318: 1651-1657.
  10. Kallenberg C. G., Cohen Tervaert J. W., Van Der Woude F. J. et al. Autoimmunity to lysosomal enzymes: new cluss to vasculitis and glomerulonephritis? Immunol. Today 1991; 12: 61- 64.
  11. Cambridge G., Rampton D. S., Stevens T. R. et al. Anti-neutrophil antibodies in inflammatory bowel diseases: Prevalence and diagnostic role. Gut 1992; 33: 668-674.
  12. Насонов Е. Л., Бекетова Т. В., Баранов А. А. и др. Антинейтрофильные цитоплазматические антитела при системных васкулитах. Клин. мед. 1992; 11-12: 21-27.
  13. Семенкова Е. Н., Бекетова Т. В., Коган Е. А. и др. Современные представления о микроскопическом полиартериите. Тер. арх. 1995; 5: 39-44.
  14. Lane S., Watts R., Shepstone L. et al. Primary systemic vasculitis: clinical features and mortality. Quart. J. Med. 2005; 98 (2): 97-111.
  15. Westman K., Bygren P., Olsson H. et al. Ralapse rate, renal survival and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. J. Am. Soc. Nephrol. 1998; 9: 842-852.
  16. Weidner S., Geuss S., Hafezi-Rachti S. et al. ANCA-associated vasculitis with renal involvement: an outcome analysis. Nephrol. Dial. Transplant. 2004; 19: 1403-1411.
  17. Eisenberger U., Fakhouri F., Vanhille Ph. et al. ANCA-negative pauci-immune renal vasculitis: histology and outcome. Nephrol. Dial. Transplant. 2005; 20 (7): 1392-1399.
  18. Ulmer M., Rautmann A., Gross W. L. Immunodiagnostic aspects of autoantibodies against myeloperoxidase. Clin. Nephrol. 1992; 37: 161-168.
  19. Насонов Е. Л., Баранов А. А., Саложин К. В. и др. Лабораторная диагностика системных васкулитов. В кн.: Насонов Е. Л. (ред.). Васкулиты и васкулопатии. Ярославль: Верхняя Волга; 1999. 173-245.
  20. Stangou M., Asimaki A., Bamichas G. et al. Factors influencing patient survival and renal function outcome in pulmonary-renal syndrome associated with ANCA (+) vasculitis: A single-center experience. J. Nephrol. 2005; 18: 35-44.
  21. Бекетова Т. В., Насонов Е. Л., Козловская Л. В. и др. Гранулематоз Вегенера: диагностическое значение определения антител к цитоплазме нейтрофилов. В кн.: Клинический диагноз - лабораторные основы. М: Лабинформ; 1997. 132-135.
  22. Hellmich В., Csernok E., Gross W. L. 20 years with ANCA: from seromarker to a major pathogenic player in vasculitis. J. Leukoc. Biol. 2003; 74: 1-2.
  23. Xiao Н., Heeringa P., Hu P. et al. Antineutrophil cytoplasmic autoantibody specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J. Clin. Invest. 2002; 110: 955- 963.
  24. Pfister H., Ollert M., Frohlich L. et al. Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener antigen) are pathogenetic in vivo. Blood 2004; 104: 1411-1418.
  25. Насонов Е. Л., Баранов А. А., Самсонов М. Ю. Этиология и патогенез системных васкулитов. В кн.: Насонов Е. Л. (ред.). Васкулиты и васкулопатии. Ярославль: Верхняя Волга; 1999. 79-136.
  26. D'Agati V. Antineutrophil cytoplasmic autoantibody and vasculitis: much more than a disease marker. J. Clin. Invest. 2002; 110: 919-921.
  27. Reumaux D., de Boer M., Meijer A. et al. Expression of myeloperoxidase (MPO) by neutrophils is nessesary for their activation by antineutrophil cytoplasmic autoantibodies (ANCA) against MPO. J. Leukoc. Biol. 2003; 73: 841-849.
  28. Williams J., Savage C. Characterization of the regulation and functional consequences of p2Iras activation in neutrophils by antineutrophil cytoplasm autoantibodies. J. Am. Soc. Nephrol. 2005; 16: 90-96.
  29. Schreiber A., Busjahn A., Luft F. et al. Membrane expression of proteinase 3 is genetically determined. J. Am. Soc. Nephrol. 2003; 14: 68-75.
  30. Rarok A., Stegeman C., Limburg P. et al. Neutrophil membrane expression of proteinase 3 (PR 3) is related to relapse in PR3- ANCA-associated vasculitis. J. Am. Soc. Nephrol. 2002; 13: 2232-2238.
  31. Esnault V., Testa A., Audrain М.et al. Alpha 1 - antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int. 1993; 43: 1329-1332.
  32. Morgan M., Harper L., Savage С Anti-neutrophil cytoplasm-associated glomerulonephritis. J. Am. Soc. Nephrol. 2006; 17: 1224-1234.
  33. Nassonov E., Samsonov M., Tilz G. et al. Serum concentrations of neopterin, soluble interleukin-2 receptor and tumor necrosis factor receptor in Wegener's granulomatosis. J. Rheumatol. 1997; 24: 666-670.
  34. Scott G., Watts R. Systemic vasculitis: epidemiology, classification and environmental factors. Ann. Rheum. Dis. 2000; 59: 161-163.
  35. Lawyer C., Henkle J., Bakir H. Nasal carrige of staphylococcal infection in Wegener's granulomatosis. Ann. Intern. Med. 1994; 121: 74-75.
  36. Matucci-Cerinic M., Jaffa A., Kahaleh B. M. Angiotensin converting enzyme: an in vitro and in vivo marker of endothelial injury. J. Lab. Clin. Med. 1992; 120: 428-433.
  37. Nazir M., Moots R. J., Exley A. et al. Serum angiotensin converting enzyme as index of activity in vasculitis. Clin. Rheumatol. 1994; 13: P342.
  38. Radford D., Luu N., Hewiins P. et al. Antineutrophil cytoplasmic antibodies stabilize adhesion and promote migration of flowing neutrophils on endothelial cells. Arthr. and Rheum. 2001; 44: 2851-2861.
  39. Beketova T., Nasonov Е., Samsonov M. et al. Serum levels of soluble intercellular adhesion molecules-1 (sICAM-1), sICAM-2 and sP-selectin in antineutrophil cytoplasmic antibodies (ANCA)-associated glomerulonephritis. In: XXXVIIth ERA-EDTA congress. Nice; 2000. abstr. 118.
  40. Rastaldi M., Ferrarij F., Crippa A. et al. Glomerular monocyte-macrophage features in ANCA-positive renal vasculitis and cryoglobulinemic nephritis. J. Am. Soc. Nephrol. 2000; 11: 2036-2043.
  41. Rossum A., Limburg P., Kallenberg C. Activation, apoptosis and clearance of neutrophils in Wegener's granulomatosis. Ann. N. Y. Acad. Sci. 2005; 1051: 1-11.
  42. Harper L., Cockwell P., Adu D. et al. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Kidney Int. 2001; 59: 1729-1738.
  43. Beketova T. V., Semencova E. N., Kupavtseva O. A. et al. Serum concentration and sizes of DNA fragments in patients with ANCA-associated necrotizing vasculitis. In: Annual European congress of rheumatology EULAR. Vienna; 2005. top. 11.
  44. Guillevin L., Cordier J., Lhote F. et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthr. and Rheum. 1997; 40: 2187-2198.
  45. Vergunst C., van Gurp E., Hagen E. et al. An index for renal outcome in ANCA-associated glomerulonephritis. Am. J. Kidney Dis. 2003; 41: 532-538.
  46. Gascin G., Jayne D., Group E. Adjunctive plasma exchange is superior to methylprednisolone in acute renal failure due to ANCA-associated glomerulonephritis. J. Am. Soc. Nephrol. 2002; 13: abstr. 2A.
  47. Booth A., Harper L., Hammad Т. et al. Prospective study of TNF alpha blocade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis. J. Am. Soc. Nephrol. 2004; 15: 717-721.
  48. Keogh K., Ytterberg S., Fervenza F. et al. Rituximab for refractery Wegener's granulomatosis: Report of a prospective, open-label pilot trial. Am. J. Respir. Crit. Care Med. 2006; 173: 180-187.
  49. Schmitt W., Hagen E., Neumann I. et al. Treatment of refractery Wegener's granulomatosis with antithymocyte globulin (ATG): An open study in 15 patients. Kidney Int. 2004; 65: 1440-1448.
  50. Helmich В., Flossmann O., Gross W. et al. EULAR recommendation for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann. Rheum. Dis. 2007; 66: 605- 617.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2008 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies